Similarly, are individuals with obesity with modest hyperleptinemia a subgroup that might be responsive to leptin therapy, with appetite suppression and reduction in fat mass in response to exogenous leptin (Figure 1)? The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.